Presentations
1. Opening and welcome
- Advancing the 3Rs for Regulatory Testing of Medicines - Sonja Beken (FAMHP)
- The Pharmaceutical Strategy’s role in strengthening the 3Rs principle - Sara Rafael Almeida (DG SANTE (EC))
2. Contribution of the FAMHP to the 3Rs
- Advancing the 3Rs at the EMA: From the Joint Expert Group on 3Rs to the new 3Rs Working Party - Sonja Beken (FAMHP)
- Non-clinical testing of human medicinal products and 3Rs - Karen Van Malderen (FAMHP)
- The risk-based approach for ATMPs – a new paradigm with 3Rs opportunities - Claire Beuneu (FAMHP)
- Implementing the 3Rs in Quality Control and Batch Release Testing–View from the Belgian OMCL - Morgan Florens (Sciensano)
- Opportunities for 3Rs Implementation in Medical Device Testing - Pieter Van de Vijver (FAMHP)
3. Stakeholder initiative on 3Rs
- Human medicines industry initiatives on 3Rs - Kirsty Reid (EFPIA)
- Stakeholder 3Rs initiatives: a view from the Animal Health industry - Cat Stirling (AnimalhealthEurope)
- An NGO view - Tina Stibbe (PETA Science Consortium International e.V.)
- The Vision and Initiatives from the European Commission to Promote Animal-free Research - Christian Desaintes (EC)
4. National 3Rs activities
- PARERE: a network for discussing the regulatory need and relevance of new testing methods and approaches – Birgit Mertens (Sciensano)
- Advancing New Approach Methodology (NAM) in Belgium through the IC-3Rs Platform - Vera Rogiers & Axelle Cooreman (IC-3Rs, VUB)
- Exploring the Use of New Approach Methodologies in Belgium via the RE-Place Database - Mieke Van Mulders (Sciensano, VUB)
- 3Rs in Toxicity Testing: Initiatives within the Belgian Society of Toxicology and Ecotoxicology - Steven Van Cruchten (Beltox, UA)
- Roundtable Discussions to Progress Reduction in Animal Use - Eveline Roose (Dept Omgeving, Vlaamse Overheid)